Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
Filed an 8-K today reporting results of operations · per SEC
Sources: SEC
From SEC filing · Not investment advice
Filed an 8-K today reporting results of operations · per SEC
From the company’s SEC filing: what was filed, no summary.
Sources: SEC
Written 8:31 AM ET · last check 7:30 PM ET
From SEC filing · Not investment adviceSign up free to see this.
Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
No sentiment yet
Votes and Bull · Bear posts, 24h. At least 5 are needed.
How do you feel about SHC?
Zacks Investment Research
Sotera Health Company (SHC) Beats Q3 Earnings and Revenue EstimatesSotera Health reported Q3 2026 earnings of $0.29 per share, beating consensus estimates of $0.27, with revenues of $324.89 million also exceeding expectations. However, the company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends ahead of the earnings release. The stock has underperformed the S&P 500 year-to-date, gaining only 0.6% versus the market's 10.2% gain.
Headlines open the publisher's site.
$SHC filed an 8-K with results (Item 2.02) at 8:11 AM ET on Tue, Nov 3.
Community opinions, not advice. Posts with a target get a receipt. How receipts work ›
